{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:12:38Z","timestamp":1781788358696,"version":"3.54.5"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T00:00:00Z","timestamp":1387497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s11926-013-0396-1","type":"journal-article","created":{"date-parts":[[2013,12,19]],"date-time":"2013-12-19T09:27:26Z","timestamp":1387445246000},"source":"Crossref","is-referenced-by-count":50,"title":["Uric Acid and Xanthine Oxidoreductase in Wound Healing"],"prefix":"10.1007","volume":"16","author":[{"given":"Melissa L.","family":"Fernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zee","family":"Upton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary K.","family":"Shooter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,20]]},"reference":[{"key":"396_CR1","first-page":"CD000265","volume":"3","author":"N Cullum","year":"2000","unstructured":"Cullum N et al. Compression for venous leg ulcers. Cochrane Database Syst Rev. 2000;3:CD000265.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"396_CR2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-4632.2004.02456.x","volume":"44","author":"LP Abbade","year":"2005","unstructured":"Abbade LP, Lastoria S. Venous ulcer: epidemiology, physiopathology, diagnosis and treatment. Int J Dermatol. 2005;44(6):449\u201356.","journal-title":"Int J Dermatol"},{"issue":"7452","key":"396_CR3","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1136\/bmj.328.7452.1358","volume":"328","author":"DA Simon","year":"2004","unstructured":"Simon DA, Dix FP, McCollum CN. Management of venous leg ulcers. Bmj. 2004;328(7452):1358\u201362.","journal-title":"Bmj"},{"issue":"4","key":"396_CR4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1445-2197.1994.tb02196.x","volume":"64","author":"SR Baker","year":"1994","unstructured":"Baker SR, Stacey MC. Epidemiology of chronic leg ulcers in Australia. Aust N Z J Surg. 1994;64(4):258\u201361.","journal-title":"Aust N Z J Surg"},{"issue":"3","key":"396_CR5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1524-475X.2009.00487.x","volume":"17","author":"SK Kurd","year":"2009","unstructured":"Kurd SK et al. Evaluation of the use of prognostic information for the care of individuals with venous leg ulcers or diabetic neuropathic foot ulcers. Wound Repair Regen. 2009;17(3):318\u201325.","journal-title":"Wound Repair Regen"},{"issue":"2A Suppl","key":"396_CR6","doi-asserted-by":"crossref","first-page":"39S","DOI":"10.1016\/S0002-9610(98)00184-6","volume":"176","author":"WK Stadelmann","year":"1998","unstructured":"Stadelmann WK, Digenis AG, Tobin GR. Impediments to wound healing. Am J Surg. 1998;176(2A Suppl):39S\u201347S.","journal-title":"Am J Surg"},{"issue":"3","key":"396_CR7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM198501173120305","volume":"312","author":"JM McCord","year":"1985","unstructured":"McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985;312(3):159\u201363.","journal-title":"N Engl J Med"},{"key":"396_CR8","unstructured":"Fernandez, M.L., et al., Elevated uric acid correlates with wound severity. Int Wound J."},{"issue":"9","key":"396_CR9","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1084\/jem.186.9.1615","volume":"186","author":"MC Montesinos","year":"1997","unstructured":"Montesinos MC et al. Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors. J Exp Med. 1997;186(9):1615\u201320.","journal-title":"J Exp Med"},{"issue":"6","key":"396_CR10","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/S0002-9440(10)61151-0","volume":"160","author":"MC Montesinos","year":"2002","unstructured":"Montesinos MC et al. Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors. Am J Pathol. 2002;160(6):2009\u201318.","journal-title":"Am J Pathol"},{"issue":"4","key":"396_CR11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s11302-006-9022-2","volume":"2","author":"S Jiang","year":"2006","unstructured":"Jiang S et al. Non-adenine based purines accelerate wound healing. Purinergic Signal. 2006;2(4):651\u201361.","journal-title":"Purinergic Signal"},{"issue":"5","key":"396_CR12","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1124\/mol.105.011783","volume":"67","author":"J Linden","year":"2005","unstructured":"Linden J. Adenosine in tissue protection and tissue regeneration. Mol Pharmacol. 2005;67(5):1385\u20137.","journal-title":"Mol Pharmacol"},{"issue":"7","key":"396_CR13","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.bcp.2008.11.002","volume":"77","author":"MD Valls","year":"2009","unstructured":"Valls MD, Cronstein BN, Montesinos MC. Adenosine receptor agonists for promotion of dermal wound healing. Biochem Pharmacol. 2009;77(7):1117\u201324.","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"396_CR14","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/art.21974","volume":"54","author":"ES Chan","year":"2006","unstructured":"Chan ES et al. Adenosine A2A receptors in diffuse dermal fibrosis: pathogenic role in human dermal fibroblasts and in a murine model of scleroderma. Arthritis Rheum. 2006;54(8):2632\u201342.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"396_CR15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/01.RES.0000012203.21416.14","volume":"90","author":"I Feoktistov","year":"2002","unstructured":"Feoktistov I et al. Differential expression of adenosine receptors in human endothelial cells: role of A2B receptors in angiogenic factor regulation. Circ Res. 2002;90(5):531\u20138.","journal-title":"Circ Res"},{"issue":"7","key":"396_CR16","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.4049\/jimmunol.167.7.4026","volume":"167","author":"ND Khoa","year":"2001","unstructured":"Khoa ND et al. Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human monocytic THP-1 cells. J Immunol. 2001;167(7):4026\u201332.","journal-title":"J Immunol"},{"key":"396_CR17","doi-asserted-by":"crossref","unstructured":"Hasko, G. and B. Cronstein, Regulation of inflammation by adenosine. Front Immunol. 4: p. 85.","DOI":"10.3389\/fimmu.2013.00085"},{"issue":"4","key":"396_CR18","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1172\/JCI114547","volume":"85","author":"BN Cronstein","year":"1990","unstructured":"Cronstein BN et al. The adenosine\/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. J Clin Invest. 1990;85(4):1150\u20137.","journal-title":"J Clin Invest"},{"issue":"3","key":"396_CR19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0014-2999(98)00619-0","volume":"358","author":"G Hasko","year":"1998","unstructured":"Hasko G et al. An agonist of adenosine A3 receptors decreases interleukin-12 and interferon-gamma production and prevents lethality in endotoxemic mice. Eur J Pharmacol. 1998;358(3):261\u20138.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"396_CR20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.pharmthera.2006.08.003","volume":"113","author":"G Hasko","year":"2007","unstructured":"Hasko G et al. Shaping of monocyte and macrophage function by adenosine receptors. Pharmacol Ther. 2007;113(2):264\u201375.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"396_CR21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.cyto.2005.05.002","volume":"31","author":"S Sipka","year":"2005","unstructured":"Sipka S et al. Adenosine inhibits the release of interleukin-1beta in activated human peripheral mononuclear cells. Cytokine. 2005;31(4):258\u201363.","journal-title":"Cytokine"},{"issue":"2 Pt 1","key":"396_CR22","doi-asserted-by":"crossref","first-page":"C522","DOI":"10.1152\/ajpcell.1996.270.2.C522","volume":"270","author":"MG Bouma","year":"1996","unstructured":"Bouma MG, van den Wildenberg FA, Buurman WA. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am J Physiol. 1996;270(2 Pt 1):C522\u20139.","journal-title":"Am J Physiol"},{"issue":"5","key":"396_CR23","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.4049\/jimmunol.155.5.2579","volume":"155","author":"DA Bullough","year":"1995","unstructured":"Bullough DA et al. Adenosine activates A2 receptors to inhibit neutrophil adhesion and injury to isolated cardiac myocytes. J Immunol. 1995;155(5):2579\u201386.","journal-title":"J Immunol"},{"issue":"3","key":"396_CR24","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1172\/JCI112638","volume":"78","author":"BN Cronstein","year":"1986","unstructured":"Cronstein BN et al. Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J Clin Invest. 1986;78(3):760\u201370.","journal-title":"J Clin Invest"},{"issue":"7","key":"396_CR25","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.4049\/jimmunol.148.7.2201","volume":"148","author":"BN Cronstein","year":"1992","unstructured":"Cronstein BN et al. Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J Immunol. 1992;148(7):2201\u20136.","journal-title":"J Immunol"},{"issue":"1","key":"396_CR26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1189\/jlb.0603300","volume":"75","author":"GW Sullivan","year":"2004","unstructured":"Sullivan GW et al. Activation of A2A adenosine receptors inhibits expression of alpha 4\/beta 1 integrin (very late antigen-4) on stimulated human neutrophils. J Leukoc Biol. 2004;75(1):127\u201334.","journal-title":"J Leukoc Biol"},{"issue":"5","key":"396_CR27","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1124\/mol.104.007807","volume":"67","author":"A Desai","year":"2005","unstructured":"Desai A et al. Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1. Mol Pharmacol. 2005;67(5):1406\u201313.","journal-title":"Mol Pharmacol"},{"issue":"2","key":"396_CR28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/art.24164","volume":"61","author":"JH Chen","year":"2009","unstructured":"Chen JH et al. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum. 2009;61(2):225\u201332.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"396_CR29","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2337\/dc09-0288","volume":"32","author":"S Kodama","year":"2009","unstructured":"Kodama S et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care. 2009;32(9):1737\u201342.","journal-title":"Diabetes Care"},{"issue":"6","key":"396_CR30","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/CIRCHEARTFAILURE.108.797662","volume":"2","author":"E Krishnan","year":"2009","unstructured":"Krishnan E. Hyperuricemia and incident heart failure. Circ Heart Fail. 2009;2(6):556\u201362.","journal-title":"Circ Heart Fail"},{"key":"396_CR31","doi-asserted-by":"crossref","unstructured":"Ghaemi-Oskouie, F. and Y. Shi, The role of uric acid as an endogenous danger signal in immunity and inflammation. Curr Rheumatol Rep. 13(2): p. 160\u20136.","DOI":"10.1007\/s11926-011-0162-1"},{"issue":"4","key":"396_CR32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/ard.33.4.313","volume":"33","author":"I Kippen","year":"1974","unstructured":"Kippen I et al. Factors affecting urate solubility in vitro. Ann Rheum Dis. 1974;33(4):313\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"396_CR33","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/art.1780230509","volume":"23","author":"HK Tak","year":"1980","unstructured":"Tak HK, Cooper SM, Wilcox WR. Studies on the nucleation of monosodium urate at 37 degrees c. Arthritis Rheum. 1980;23(5):574\u201380.","journal-title":"Arthritis Rheum"},{"key":"396_CR34","doi-asserted-by":"crossref","unstructured":"Jin, M., et al., Uric acid, hyperuricemia and vascular diseases. Front Biosci (Landmark Ed). 17: p. 656\u201369.","DOI":"10.2741\/3950"},{"issue":"7081","key":"396_CR35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440(7081):237\u201341.","journal-title":"Nature"},{"issue":"8","key":"396_CR36","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle A et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol. 2008;9(8):857\u201365.","journal-title":"Nat Immunol"},{"issue":"8","key":"396_CR37","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ni.1631","volume":"9","author":"V Hornung","year":"2008","unstructured":"Hornung V et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 2008;9(8):847\u201356.","journal-title":"Nat Immunol"},{"issue":"4","key":"396_CR38","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1046\/j.1524-475X.1996.40404.x","volume":"4","author":"BA Mast","year":"1996","unstructured":"Mast BA, Schultz GS. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen. 1996;4(4):411\u201320.","journal-title":"Wound Repair Regen"},{"issue":"2","key":"396_CR39","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1046\/j.1524-475X.1996.40211.x","volume":"4","author":"NJ Trengove","year":"1996","unstructured":"Trengove NJ, Langton SR, Stacey MC. Biochemical analysis of wound fluid from nonhealing and healing chronic leg ulcers. Wound Repair Regen. 1996;4(2):234\u20139.","journal-title":"Wound Repair Regen"},{"issue":"6","key":"396_CR40","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1524-475X.1999.00442.x","volume":"7","author":"NJ Trengove","year":"1999","unstructured":"Trengove NJ et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen. 1999;7(6):442\u201352.","journal-title":"Wound Repair Regen"},{"issue":"1","key":"396_CR41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.0105-2896.2009.00851.x","volume":"233","author":"Y Shi","year":"2010","unstructured":"Shi Y, Mucsi AD, Ng G. Monosodium urate crystals in inflammation and immunity. Immunol Rev. 2010;233(1):203\u201317.","journal-title":"Immunol Rev"},{"issue":"10","key":"396_CR42","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1136\/ard.2009.109355","volume":"68","author":"R Torres","year":"2009","unstructured":"Torres R et al. Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis. Ann Rheum Dis. 2009;68(10):1602\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"396_CR43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF01375654","volume":"16","author":"T Akahoshi","year":"1997","unstructured":"Akahoshi T et al. Prevention of neutrophil apoptosis by monosodium urate crystals. Rheumatol Int. 1997;16(6):231\u20135.","journal-title":"Rheumatol Int"},{"key":"396_CR44","doi-asserted-by":"crossref","unstructured":"Popa-Nita, O. and P.H. Naccache, Crystal-induced neutrophil activation. Immunol Cell Biol. 88(1): p. 32\u201340.","DOI":"10.1038\/icb.2009.98"},{"key":"396_CR45","doi-asserted-by":"crossref","unstructured":"Kono, H., et al., Uric acid promotes an acute inflammatory response to sterile cell death in mice. J Clin Invest. 120(6): p. 1939\u201349.","DOI":"10.1172\/JCI40124"},{"key":"396_CR46","doi-asserted-by":"crossref","first-page":"452","DOI":"10.7326\/0003-4819-54-3-452","volume":"54","author":"DJ McCarty","year":"1961","unstructured":"McCarty DJ, Hollander JL. Identification of urate crystals in gouty synovial fluid. Ann Intern Med. 1961;54:452\u201360.","journal-title":"Ann Intern Med"},{"issue":"11","key":"396_CR47","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","volume":"78","author":"BN Ames","year":"1981","unstructured":"Ames BN et al. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A. 1981;78(11):6858\u201362.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"396_CR48","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1042\/bj2350747","volume":"235","author":"KJ Davies","year":"1986","unstructured":"Davies KJ et al. Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J. 1986;235(3):747\u201354.","journal-title":"Biochem J"},{"issue":"2","key":"396_CR49","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1006\/abbi.2000.1721","volume":"376","author":"GL Squadrito","year":"2000","unstructured":"Squadrito GL et al. Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch Biochem Biophys. 2000;376(2):333\u20137.","journal-title":"Arch Biochem Biophys"},{"issue":"2\u20133","key":"396_CR50","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0009-2797(90)90006-9","volume":"73","author":"H Kaur","year":"1990","unstructured":"Kaur H, Halliwell B. Action of biologically-relevant oxidizing species upon uric acid. Identification of uric acid oxidation products. Chem Biol Interact. 1990;73(2\u20133):235\u201347.","journal-title":"Chem Biol Interact"},{"issue":"32","key":"396_CR51","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.2174\/138161205774913255","volume":"11","author":"GK Glantzounis","year":"2005","unstructured":"Glantzounis GK et al. Uric acid and oxidative stress. Curr Pharm Des. 2005;11(32):4145\u201351.","journal-title":"Curr Pharm Des"},{"issue":"5","key":"396_CR52","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1067-1927.2005.00065.x","volume":"13","author":"M Wlaschek","year":"2005","unstructured":"Wlaschek M, Scharffetter-Kochanek K. Oxidative stress in chronic venous leg ulcers. Wound Repair Regen. 2005;13(5):452\u201361.","journal-title":"Wound Repair Regen"},{"issue":"1","key":"396_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0898-6568(98)00037-0","volume":"11","author":"H Kamata","year":"1999","unstructured":"Kamata H, Hirata H. Redox regulation of cellular signalling. Cell Signal. 1999;11(1):1\u201314.","journal-title":"Cell Signal"},{"issue":"1","key":"396_CR54","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1152\/physrev.00018.2001","volume":"82","author":"W Droge","year":"2002","unstructured":"Droge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82(1):47\u201395.","journal-title":"Physiol Rev"},{"issue":"4\u20135","key":"396_CR55","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1751-1097.1978.tb07009.x","volume":"28","author":"I Fridovich","year":"1978","unstructured":"Fridovich I. Superoxide radicals, superoxide dismutases and the aerobic lifestyle. Photochem Photobiol. 1978;28(4\u20135):733\u201341.","journal-title":"Photochem Photobiol"},{"issue":"3","key":"396_CR56","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0006-2952(90)90043-K","volume":"39","author":"C Deby","year":"1990","unstructured":"Deby C, Goutier R. New perspectives on the biochemistry of superoxide anion and the efficiency of superoxide dismutases. Biochem Pharmacol. 1990;39(3):399\u2013405.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"396_CR57","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0899-9007(96)00000-8","volume":"12","author":"EM Conner","year":"1996","unstructured":"Conner EM, Grisham MB. Inflammation, free radicals, and antioxidants. Nutrition. 1996;12(4):274\u20137.","journal-title":"Nutrition"},{"issue":"5","key":"396_CR58","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/1523-1747.ep12374036","volume":"102","author":"D Darr","year":"1994","unstructured":"Darr D, Fridovich I. Free radicals in cutaneous biology. J Invest Dermatol. 1994;102(5):671\u20135.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"396_CR59","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00007256-200636040-00004","volume":"36","author":"J Finaud","year":"2006","unstructured":"Finaud J, Lac G, Filaire E. Oxidative stress : relationship with exercise and training. Sports Med. 2006;36(4):327\u201358.","journal-title":"Sports Med"},{"issue":"10","key":"396_CR60","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2174\/0929867053764635","volume":"12","author":"M Valko","year":"2005","unstructured":"Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Curr Med Chem. 2005;12(10):1161\u2013208.","journal-title":"Curr Med Chem"},{"key":"396_CR61","volume-title":"Free radicals in biology and medicine","author":"B Halliwell","year":"1999","unstructured":"Halliwell B, Gutteridge J. Free radicals in biology and medicine. Thirdth ed. New York: Oxford University Press Inc; 1999.","edition":"Third"},{"issue":"6","key":"396_CR62","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1080\/01926230290166724","volume":"30","author":"R Kohen","year":"2002","unstructured":"Kohen R, Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol. 2002;30(6):620\u201350.","journal-title":"Toxicol Pathol"},{"issue":"2\u20133","key":"396_CR63","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0962-8924(91)90072-H","volume":"1","author":"R Schreck","year":"1991","unstructured":"Schreck R, Baeuerle PA. A role for oxygen radicals as second messengers. Trends Cell Biol. 1991;1(2\u20133):39\u201342.","journal-title":"Trends Cell Biol"},{"issue":"5","key":"396_CR64","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/j.1460-2075.1993.tb05850.x","volume":"12","author":"M Meyer","year":"1993","unstructured":"Meyer M, Schreck R, Baeuerle PA. H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. Embo J. 1993;12(5):2005\u201315.","journal-title":"Embo J"},{"issue":"3","key":"396_CR65","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0891-5849(96)00109-8","volume":"21","author":"Y Sun","year":"1996","unstructured":"Sun Y, Oberley LW. Redox regulation of transcriptional activators. Free Radic Biol Med. 1996;21(3):335\u201348.","journal-title":"Free Radic Biol Med"},{"issue":"36","key":"396_CR66","doi-asserted-by":"crossref","first-page":"25869","DOI":"10.1074\/jbc.274.36.25869","volume":"274","author":"J Wenk","year":"1999","unstructured":"Wenk J et al. Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1. J Biol Chem. 1999;274(36):25869\u201376.","journal-title":"J Biol Chem"},{"issue":"9","key":"396_CR67","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood.V92.9.3007","volume":"92","author":"MB Hampton","year":"1998","unstructured":"Hampton MB, Kettle AJ, Winterbourn CC. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood. 1998;92(9):3007\u201317.","journal-title":"Blood"},{"issue":"1","key":"396_CR68","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pharmthera.2005.06.023","volume":"111","author":"D Lau","year":"2006","unstructured":"Lau D, Baldus S. Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacol Ther. 2006;111(1):16\u201326.","journal-title":"Pharmacol Ther"},{"issue":"4688","key":"396_CR69","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1126\/science.2982211","volume":"227","author":"SJ Weiss","year":"1985","unstructured":"Weiss SJ et al. Oxidative autoactivation of latent collagenase by human neutrophils. Science. 1985;227(4688):747\u20139.","journal-title":"Science"},{"issue":"44","key":"396_CR70","doi-asserted-by":"crossref","first-page":"41279","DOI":"10.1074\/jbc.M106958200","volume":"276","author":"X Fu","year":"2001","unstructured":"Fu X et al. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem. 2001;276(44):41279\u201387.","journal-title":"J Biol Chem"},{"issue":"5","key":"396_CR71","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1365-2133.2008.08462.x","volume":"158","author":"EA Rayment","year":"2008","unstructured":"Rayment EA, Upton Z, Shooter GK. Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer. Br J Dermatol. 2008;158(5):951\u201361.","journal-title":"Br J Dermatol"},{"issue":"4903","key":"396_CR72","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1126\/science.2497518","volume":"244","author":"B Hoyos","year":"1989","unstructured":"Hoyos B et al. Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression. Science. 1989;244(4903):457\u201360.","journal-title":"Science"},{"issue":"5","key":"396_CR73","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1128\/MCB.10.5.2327","volume":"10","author":"TA Libermann","year":"1990","unstructured":"Libermann TA, Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol. 1990;10(5):2327\u201334.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"396_CR74","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.171.1.35","volume":"171","author":"AN Shakhov","year":"1990","unstructured":"Shakhov AN et al. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J Exp Med. 1990;171(1):35\u201347.","journal-title":"J Exp Med"},{"issue":"2","key":"396_CR75","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-4165(98)00028-2","volume":"1381","author":"S Page","year":"1998","unstructured":"Page S et al. Xanthine oxidoreductase in human mammary epithelial cells: activation in response to inflammatory cytokines. Biochim Biophys Acta. 1998;1381(2):191\u2013202.","journal-title":"Biochim Biophys Acta"},{"key":"396_CR76","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.genet.37.110801.142538","volume":"37","author":"MS Paget","year":"2003","unstructured":"Paget MS, Buttner MJ. Thiol-based regulatory switches. Annu Rev Genet. 2003;37:91\u2013121.","journal-title":"Annu Rev Genet"},{"issue":"7","key":"396_CR77","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2174\/0929867013372904","volume":"8","author":"LK Moran","year":"2001","unstructured":"Moran LK, Gutteridge JM, Quinlan GJ. Thiols in cellular redox signalling and control. Curr Med Chem. 2001;8(7):763\u201372.","journal-title":"Curr Med Chem"},{"issue":"3\u20134","key":"396_CR78","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00726-003-0016-x","volume":"25","author":"CL Hawkins","year":"2003","unstructured":"Hawkins CL, Pattison DI, Davies MJ. Hypochlorite-induced oxidation of amino acids, peptides and proteins. Amino Acids. 2003;25(3\u20134):259\u201374.","journal-title":"Amino Acids"},{"issue":"4","key":"396_CR79","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cell.2008.09.024","volume":"135","author":"J Winter","year":"2008","unstructured":"Winter J et al. Bleach activates a redox-regulated chaperone by oxidative protein unfolding. Cell. 2008;135(4):691\u2013701.","journal-title":"Cell"},{"issue":"9","key":"396_CR80","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1089\/ars.2008.2063","volume":"10","author":"A Bindoli","year":"2008","unstructured":"Bindoli A, Fukuto JM, Forman HJ. Thiol chemistry in peroxidase catalysis and redox signaling. Antioxid Redox Signal. 2008;10(9):1549\u201364.","journal-title":"Antioxid Redox Signal"},{"key":"396_CR81","volume-title":"Skin Breakdown, The Silent Epidemic","author":"J Posnett","year":"2007","unstructured":"Posnett J, Franks PJ. Skin Breakdown, The Silent Epidemic. London, UK: Smith and Nephew; 2007."},{"issue":"2","key":"396_CR82","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/0929867023371229","volume":"9","author":"F Borges","year":"2002","unstructured":"Borges F, Fernandes E, Roleira F. Progress towards the discovery of xanthine oxidase inhibitors. Curr Med Chem. 2002;9(2):195\u2013217.","journal-title":"Curr Med Chem"},{"issue":"1","key":"396_CR83","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/pr.58.1.6","volume":"58","author":"P Pacher","year":"2006","unstructured":"Pacher P, Nivorozhkin A, Szabo C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006;58(1):87\u2013114.","journal-title":"Pharmacol Rev"},{"key":"396_CR84","unstructured":"Allopurinol Tablets USP, DailyMed Current Medication Information."},{"issue":"5","key":"396_CR85","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/112067210201200504","volume":"12","author":"W Sekundo","year":"2002","unstructured":"Sekundo W, Augustin AJ, Strempel I. Topical allopurinol or corticosteroids and acetylcysteine in the early treatment of experimental corneal alkali burns: a pilot study. Eur J Ophthalmol. 2002;12(5):366\u201372.","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"396_CR86","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1269\/jrr.07038","volume":"49","author":"J Kitagawa","year":"2008","unstructured":"Kitagawa J et al. Allopurinol gel mitigates radiation-induced mucositis and dermatitis. J Radiat Res (Tokyo). 2008;49(1):49\u201354.","journal-title":"J Radiat Res (Tokyo)"},{"issue":"1","key":"396_CR87","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF00163854","volume":"34","author":"XW Wu","year":"1992","unstructured":"Wu XW et al. Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol. 1992;34(1):78\u201384.","journal-title":"J Mol Evol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-013-0396-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-013-0396-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-013-0396-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T06:08:11Z","timestamp":1688882891000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-013-0396-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,20]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["396"],"URL":"https:\/\/doi.org\/10.1007\/s11926-013-0396-1","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,20]]},"article-number":"396"}}